143 related articles for article (PubMed ID: 30677268)
1. NIMH Drug Trials for Schizophrenia.
Torrey EF; Yolken RH; Lamb HR
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677268
[No Abstract] [Full Text] [Related]
2. The NIMH-MATRICS consensus statement on negative symptoms.
Kirkpatrick B; Fenton WS; Carpenter WT; Marder SR
Schizophr Bull; 2006 Apr; 32(2):214-9. PubMed ID: 16481659
[No Abstract] [Full Text] [Related]
3. Cognitive neuroscience and schizophrenia: translational research in need of a translator.
Cohen JD; Insel TR
Biol Psychiatry; 2008 Jul; 64(1):2-3. PubMed ID: 18549873
[No Abstract] [Full Text] [Related]
4. Behavioral science. NIMH takes a new tack, upsetting behavioral researchers.
Holden C
Science; 2004 Oct; 306(5696):602. PubMed ID: 15498989
[No Abstract] [Full Text] [Related]
5. NIMH review of fraud charge moves slowly.
Holden C
Science; 1986 Dec; 234(4783):1488-9. PubMed ID: 2878494
[No Abstract] [Full Text] [Related]
6. Perspective: Retreat from the radical.
Marder SR
Nature; 2014 Apr; 508(7494):S18. PubMed ID: 24695331
[No Abstract] [Full Text] [Related]
7. NIMH finds a case of "serious misconduct".
Holden C
Science; 1987 Mar; 235(4796):1566-7. PubMed ID: 2881355
[No Abstract] [Full Text] [Related]
8. The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia.
Marder SR
Dialogues Clin Neurosci; 2006; 8(1):109-13. PubMed ID: 16640121
[TBL] [Abstract][Full Text] [Related]
9. Reducing dosage in maintenance treatment of schizophrenia. Review and prognosis.
Schooler NR
Br J Psychiatry Suppl; 1993 Dec; (22):58-65. PubMed ID: 7906525
[TBL] [Abstract][Full Text] [Related]
10. New strategies in the search of antipsychotic drugs.
Adell A
Curr Pharm Des; 2010; 16(5):486-7. PubMed ID: 20236076
[No Abstract] [Full Text] [Related]
11. An industry perspective on the NIMH consensus statement on negative symptoms.
Alphs L
Schizophr Bull; 2006 Apr; 32(2):225-30. PubMed ID: 16469940
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Antipsychotic Trials of Intervention Effectiveness: what did we learn?
Boyd MA
Arch Psychiatr Nurs; 2008 Feb; 22(1):56-8. PubMed ID: 18207059
[No Abstract] [Full Text] [Related]
13. Pharmacoeconomic factors related to the treatment of schizophrenia. Concluding discussion.
J Clin Psychiatry; 1999; 60 Suppl 3():59-60. PubMed ID: 10073380
[No Abstract] [Full Text] [Related]
14. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
Swartz MS; Perkins DO; Stroup TS; Davis SM; Capuano G; Rosenheck RA; Reimherr F; McGee MF; Keefe RS; McEvoy JP; Hsiao JK; Lieberman JA;
Am J Psychiatry; 2007 Mar; 164(3):428-36. PubMed ID: 17329467
[TBL] [Abstract][Full Text] [Related]
15. Psychotherapy Research and the NIMH: An Either/Or or Both/And Research Agenda?
Plakun EM
J Psychiatr Pract; 2017 Mar; 23(2):130-133. PubMed ID: 28291038
[TBL] [Abstract][Full Text] [Related]
16. Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study.
Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1078-85. PubMed ID: 24726579
[TBL] [Abstract][Full Text] [Related]
17. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.
Stroup TS; McEvoy JP; Swartz MS; Byerly MJ; Glick ID; Canive JM; McGee MF; Simpson GM; Stevens MC; Lieberman JA
Schizophr Bull; 2003; 29(1):15-31. PubMed ID: 12908658
[TBL] [Abstract][Full Text] [Related]
18. Using the NIH Research, Condition and Disease Categorization Database for research advocacy: Schizophrenia research at NIMH as an example.
Torrey EF; Knable MB; Rush AJ; Simmons WW; Snook J; Jaffe DJ
PLoS One; 2020; 15(11):e0241062. PubMed ID: 33211693
[TBL] [Abstract][Full Text] [Related]
19. Interpreting the results of the CATIE study.
Luchins DJ
Psychiatr Serv; 2006 Jan; 57(1):139-40. PubMed ID: 16399979
[No Abstract] [Full Text] [Related]
20. Antipsychotics: Past and Future: National Institute of Mental Health Division of Services and Intervention Research Workshop, July 14, 1998.
Dawkins K; Lieberman JA; Lebowitz BD; Hsiao JK
Schizophr Bull; 1999; 25(2):395-405. PubMed ID: 10416740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
